Aderbal Silva Aguiar Júnior

Laboratório Biologia
do Exercício Físico
(LaBioEx)

 Bachelor in physiotherapy (UDESC) with specialization (UNIFESP) and Master’s degree (UNESC) in exercise physiology, Ph.D. in pharmacology (UFSC) with a period at INSERMUPMC in Paris. Post-doctoral research at the PPGBQA/UFSC (2011-13) and at the Center for Neurosciences and Cell Biology from the University of Coimbra (Portugal).

“His line of research is focused on a) neurobiology of physical exercise and the disease-modifying effects in experimental models of diseases; b) pharmacology and sport genetics, the role of ergogenic resources and genomic factors “

Ongoing projects:
a) RE2SCUE: REpiracy REHABILITATION in Survivors of 2 COVID-19. A randomized clinical trial.
b) The role of A2A adenosinergic receptors in central fatigue in animal models of neurological diseases.

Main Publications:

Exercise, redox system and neurodegenerative diseases. Biochimica et Biophysica acta – Molecular Basis of Disease, v. 1866, p. 165778, 2020.

Neuronal adenosine A2A receptors signal ergogenic effects of caffeine. Scientific Reports, v. 10, p. 1-10, 2020.

The Role of PGC-1α/UCP2 Signaling in the Beneficial Effects of Physical Exercise on the Brain. Frontiers in Neuroscience, v. 13, p. 292, 2019.

The exercise sex gap and the impact of the estrous cycle on exercise performance in mice. Scientific Reports, v. 8, p. 1-8, 2018.